Liposomes.

Liposomes. Part D /

Liposomes are cellular structures made up of lipid molecules. Important as a cellular model in the study of basic biology, liposomes are also used in clinical applications such as drug delivery and virus studies. Liposomes Part D is a continuation of previous MIE Liposome volumes A, B, and C. Conten...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Άλλοι συγγραφείς: Düzgüneş, Nejat
Μορφή: Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: San Diego, Calif. : Elsevier Academic Press, ©2004.
Σειρά:Methods in enzymology ; v. 387.
Θέματα:
Liposomes.
Liposomes > Handbooks, manuals, etc.
SCIENCE > Life Sciences > Biochemistry.
Electronic books.
Handbooks and manuals.
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • Section I. Antibody-or ligand-targeted liposomes
  • 1. High-yield coupling of antibody fab fragments to liposomes containing maleimide-functionalized lipids
  • 2. Interactions of hyaluronan-targeted liposomes with cultured cells: modeling of binding and endocytosis
  • 3. Folate receptor-mediated targeting of liposomal drugs to cancer cells
  • 4. Preparation of poly(ethylene glycol)-grafted liposomes with ligands at the extremeties of polymer chains
  • Section II. Environment-sensitive liposomes
  • 5. Temperature-sensitive liposomes
  • 6. The materials engineering of temperature-sensitive liposomes
  • 7. Tunable pH-sensitive liposomes
  • 8. Sterically stabilized pH-sensitive liposomes
  • 9. Improved preparation of PEG-diortho ester-diacyl glycerol conjugates
  • 10. Preparation of plasmenylcholine lipids and plasmenyl-type liposome dispersions
  • Section III. Liposomal oligonucleotides
  • 11. High efficiency entrapment of antisense oligonucleotides in liposomes
  • 12. Cationic liposomes/ lipids for oligonucleotide delivery: application to the inhibition of tumorigenicity of Kaposi's Sarcoma by vascular endothelial growth factor antisense oligodeoxynucleotides
  • 13. Requirements for delivery of active antisense oligonucleotides into cells with lipid carriers
  • 14. Mass spectrometry and enzyme-linked immunosorbent assay methods for the quantitation of liposomal antisense oligonucleotide (LE-rafAON) in human plasma
  • 15. Liposomal antisense oligonucleotides for cancer therapy
  • Section IV. Liposomes in vivo
  • 16. Biodistribution and uptake of liposomes in vivo
  • 17. Transport of liposome-entrapped substances into skin as measured by electron paramagnetic resonance oximetry in vivo
  • 18. Liposomal gels for vaginal drug delivery
  • 19. Use of nitroxides to protect liposomes against oxidative damage.

Παρόμοια τεκμήρια